Novel Classification System of Adenoids Based on Appearance and Its Relationship with Drug Therapy
Conclusion: AR was the risk factor for the development of edematous AH. All subtypes of AH responded to montelukast, while there was an additional effect of nasal glucocorticoid in the edematous type. A combination therapy of nasal glucocorticoid with leukotriene receptor antagonist can be recommended for AH patients with AR, patients with edematous adenoids, and/or patients with increased eosinophils in blood routine.Int Arch Allergy Immunol
Source: International Archives of Allergy and Immunology - Category: Allergy & Immunology Source Type: research
More News: Adenoidectomy | Adenoids | Allergy | Allergy & Immunology | Anesthesia | Anesthesiology | Child Development | Children | Endoscopy | Hay Fever | Obstructive Sleep Apnea | Sleep Apnea | Sleep Disorders | Sleep Medicine | Statistics | Tonsillectomy and Adenoidectomy